Acurx Pharmaceuticals, INC. (ACXP) — 8-K Filings

8-K Filings (18)

• 8-K Filing — Apr 16, 2026
• Acurx Pharmaceuticals Files 8-K — Sep 22, 2025 Risk: low
  Acurx Pharmaceuticals, Inc. filed an 8-K on September 22, 2025, reporting amendments to its articles of incorporation or bylaws and financial statements. The co
• Acurx Pharmaceuticals Files 8-K on Shareholder Vote — Sep 19, 2025 Risk: low
  Acurx Pharmaceuticals, Inc. filed an 8-K on September 19, 2025, reporting on a submission of matters to a vote of security holders that occurred on September 16
• Acurx Pharmaceuticals Files 8-K with Key Updates — Jul 31, 2025 Risk: medium
  Acurx Pharmaceuticals, Inc. filed an 8-K on July 31, 2025, reporting material modifications to security holder rights and other events. The filing also includes
• Acurx Pharmaceuticals Files 8-K on Shareholder Votes — Jul 17, 2025 Risk: low
  Acurx Pharmaceuticals, Inc. filed an 8-K on July 17, 2025, to report on matters submitted to a vote of its security holders. The filing does not contain specifi
• Acurx Pharmaceuticals Files 8-K with Material Agreements — Jun 20, 2025 Risk: medium
  On June 17, 2025, Acurx Pharmaceuticals, Inc. entered into a Material Definitive Agreement. The company also reported on unregistered sales of equity securities
• Acurx Pharmaceuticals Files 8-K on Financials — May 13, 2025 Risk: low
  Acurx Pharmaceuticals, Inc. filed an 8-K on May 13, 2025, reporting on its results of operations and financial condition. The filing includes financial statemen
• Acurx Pharmaceuticals Files 8-K on Agreements and Equity Sales — May 8, 2025 Risk: medium
  Acurx Pharmaceuticals, Inc. filed an 8-K on May 8, 2025, reporting on the entry into a material definitive agreement and unregistered sales of equity securities
• Acurx Pharmaceuticals Faces Delisting Notice — Mar 28, 2025 Risk: high
  Acurx Pharmaceuticals, Inc. received a notice on March 25, 2025, indicating a failure to meet a continued listing rule or standard, potentially leading to a tra
• Acurx Pharmaceuticals Files 8-K on Financials — Mar 18, 2025 Risk: low
  Acurx Pharmaceuticals, Inc. filed an 8-K on March 18, 2025, reporting on its results of operations and financial condition. The filing includes financial statem
• Acurx Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — Mar 10, 2025 Risk: medium
  On March 6, 2025, Acurx Pharmaceuticals, Inc. entered into a material definitive agreement. The company also reported on unregistered sales of equity securities
• Acurx Pharmaceuticals Faces Delisting Concerns — Feb 26, 2025 Risk: high
  Acurx Pharmaceuticals, Inc. filed an 8-K on February 26, 2025, reporting a notice of delisting or failure to satisfy a continued listing rule or standard. The f
• Acurx Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — Jan 7, 2025 Risk: medium
  Acurx Pharmaceuticals, Inc. entered into a material definitive agreement on January 6, 2025. The company also reported unregistered sales of equity securities a
• Acurx Pharmaceuticals Files 8-K for Financial Updates — Nov 13, 2024 Risk: low
  Acurx Pharmaceuticals, Inc. filed an 8-K on November 13, 2024, to report on its results of operations and financial condition, as well as to file financial stat
• Acurx Pharmaceuticals Files 8-K — Aug 9, 2024 Risk: low
  Acurx Pharmaceuticals, Inc. filed an 8-K on August 9, 2024, reporting on its results of operations and financial condition, as well as financial statements and
• Acurx Pharmaceuticals Files 8-K on Shareholder Vote Matters — Jun 17, 2024 Risk: low
  Acurx Pharmaceuticals, Inc. filed an 8-K on June 17, 2024, to report on matters submitted to a vote of its security holders. The filing details the company's co
• Acurx Pharmaceuticals Files 8-K on Financials — May 15, 2024 Risk: low
  Acurx Pharmaceuticals, Inc. filed an 8-K on May 15, 2024, reporting on its results of operations and financial condition. The filing includes financial statemen
• Acurx Pharmaceuticals Files 8-K — Mar 18, 2024 Risk: low
  Acurx Pharmaceuticals, Inc. filed an 8-K on March 18, 2024, reporting on its results of operations and financial condition, as well as financial statements and

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX